SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-16-097385
Filing Date
2016-04-29
Accepted
2016-04-29 08:02:59
Documents
5
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A v437652_defa14a.htm DEFA14A 12853
2 GRAPHIC image_001.jpg GRAPHIC 66349
3 GRAPHIC image_002.jpg GRAPHIC 111653
4 GRAPHIC image_003.jpg GRAPHIC 33271
5 GRAPHIC image_004.jpg GRAPHIC 5615
  Complete submission text file 0001144204-16-097385.txt   311440
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36357 | Film No.: 161602564
SIC: 2834 Pharmaceutical Preparations